company background image
301122 logo

Caina Technology SZSE:301122 Stock Report

Last Price

CN¥20.86

Market Cap

CN¥2.6b

7D

-5.7%

1Y

-35.5%

Updated

24 Dec, 2024

Data

Company Financials +

Caina Technology Co., Ltd.

SZSE:301122 Stock Report

Market Cap: CN¥2.6b

301122 Stock Overview

Engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. More details

301122 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance1/6
Financial Health6/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Caina Technology Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Caina Technology
Historical stock prices
Current Share PriceCN¥20.86
52 Week HighCN¥34.50
52 Week LowCN¥14.61
Beta0.61
1 Month Change-9.93%
3 Month Change29.73%
1 Year Change-35.52%
3 Year Changen/a
5 Year Changen/a
Change since IPO-62.58%

Recent News & Updates

Optimistic Investors Push Caina Technology Co., Ltd. (SZSE:301122) Shares Up 27% But Growth Is Lacking

Nov 19
Optimistic Investors Push Caina Technology Co., Ltd. (SZSE:301122) Shares Up 27% But Growth Is Lacking

Some May Be Optimistic About Caina Technology's (SZSE:301122) Earnings

Nov 06
Some May Be Optimistic About Caina Technology's (SZSE:301122) Earnings

Recent updates

Optimistic Investors Push Caina Technology Co., Ltd. (SZSE:301122) Shares Up 27% But Growth Is Lacking

Nov 19
Optimistic Investors Push Caina Technology Co., Ltd. (SZSE:301122) Shares Up 27% But Growth Is Lacking

Some May Be Optimistic About Caina Technology's (SZSE:301122) Earnings

Nov 06
Some May Be Optimistic About Caina Technology's (SZSE:301122) Earnings

This Broker Just Slashed Their Caina Technology Co., Ltd. (SZSE:301122) Earnings Forecasts

Aug 30
This Broker Just Slashed Their Caina Technology Co., Ltd. (SZSE:301122) Earnings Forecasts

The Returns On Capital At Caina Technology (SZSE:301122) Don't Inspire Confidence

Aug 23
The Returns On Capital At Caina Technology (SZSE:301122) Don't Inspire Confidence

Caina Technology's (SZSE:301122) Problems Go Beyond Weak Profit

May 01
Caina Technology's (SZSE:301122) Problems Go Beyond Weak Profit

The Returns On Capital At Caina Technology (SZSE:301122) Don't Inspire Confidence

Mar 12
The Returns On Capital At Caina Technology (SZSE:301122) Don't Inspire Confidence

Shareholder Returns

301122CN Medical EquipmentCN Market
7D-5.7%0.1%0.4%
1Y-35.5%-8.5%12.3%

Return vs Industry: 301122 underperformed the CN Medical Equipment industry which returned -10.4% over the past year.

Return vs Market: 301122 underperformed the CN Market which returned 9.8% over the past year.

Price Volatility

Is 301122's price volatile compared to industry and market?
301122 volatility
301122 Average Weekly Movement10.0%
Medical Equipment Industry Average Movement8.6%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 301122 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 301122's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004689Jun Luwww.caina.ltd

Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd.

Caina Technology Co., Ltd. Fundamentals Summary

How do Caina Technology's earnings and revenue compare to its market cap?
301122 fundamental statistics
Market capCN¥2.55b
Earnings (TTM)CN¥77.32m
Revenue (TTM)CN¥409.00m

33.0x

P/E Ratio

6.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301122 income statement (TTM)
RevenueCN¥409.00m
Cost of RevenueCN¥249.54m
Gross ProfitCN¥159.46m
Other ExpensesCN¥82.13m
EarningsCN¥77.32m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.63
Gross Margin38.99%
Net Profit Margin18.91%
Debt/Equity Ratio0%

How did 301122 perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

35%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 05:09
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Caina Technology Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Feifei XuChina Merchants Securities (HK) Co., Ltd
Wen DaiHuatai Research
Song YangTianfeng Securities Brokerage Co., Ltd